Immune thrombocytopenia (ITP) is a common hematological manifestation of systemic lupus
erythematosus (SLE). The heterogeneity of its clinical characteristics and therapeutic …

Objectives To describe the characteristics, treatment and outcome of patients with immune
thrombocytopenia with clinical significance (ITPCS) associated with SLE. Methods This …

Systemic Lupus Erythematosus (SLE) is frequently complicated by cytopenias.
Thrombocytopenia is usually non severe and its frequency ranges from 20% to 40%. It is …

Immune thrombocytopenia (IT) is a common manifestation of systemic lupus erythematosus
(SLE). Although severe IT (< 20× 10 9/L) occurs in about 5-10% of patients, usually in the …

Objectives: To clarify clinical manifestations, association with disease activity, and
prognostic impact of thrombocytopenia using simple and reliable indices. Methods: 632 …

Although corticosteroids, intravenous immunoglobulin and splenectomy have proven to be
effective measures to treat immune thrombocytopenia, newer studies have demonstrated …

OBJECTIVE: To evaluate the response to treatment in a large cohort of patients with
systemic lupus erythematosus (SLE) associated with autoimmune thrombocytopenia …

Immune-mediated thrombocytopenic purpura (ITP) is recognized as a cell-specific
autoimmune disorder, yet, multifactorial in origin. The development of thrombocytopenia is …

Thrombocytopenia in Systemic Lupus Erythematosus: Clinical M... : Medicine Thrombocytopenia
in Systemic Lupus Erythematosus: Clinical Manifestations, Treatment, and Prognosis in 230 …

Immune thrombocytopenia (ITP) is a rare autoimmune disorder caused by peripheral
platelet destruction and inappropriate bone marrow production. The management of ITP is …